Cannara Biotech Inc. shares have shown a modest gain this week following significant financing news.
This week, Cannara Biotech Inc. (LOVE.TO) experienced a slight uptick of 1.53%, closing at C$2.00. The stock has gained 8.15% year-to-date, reflecting a steady upward trend amid recent developments in the company's financial strategy.
Advertisement
Cannara Biotech Inc.
LOVE.TO
LOVE.TO
Cannara Biotech Inc.
WealthAwesomeMarket cap
$196.58M
P/E
18.1x
52W high
$2.07
52W low
$1.55
1W change
+1.53%
Beta
0.36
Analyst Price Targets
Based on analyst covering LOVE · as of Sep 17, 2026
Wall Street analysts forecast LOVE stock price to rise 69.6% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$3.38
+69.6% Upside
Current Price
C$1.99
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on LOVE's historical volatility
30-Day Vol
19.3%
Annualized
90-Day Vol
29.4%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$2.39
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$2.12 | C$1.99 – C$2.27 |
| 60 trading days | C$2.25 | C$2.05 – C$2.48 |
| 90 trading days | C$2.39 | C$2.13 – C$2.68 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: The recent expansion of Cannara's financing through a syndicated credit facility may bolster investor confidence, positioning the company for further growth in the competitive cannabis sector.
C$2.00 Closing Price with a 1D Change of 0.00%
Cannara’s stock has shown resilience with a 52-week range of C$1.55 to C$2.07, indicating a stable trading environment.
Bull case
The establishment of an $80 million syndicated credit facility with BMO and TD Bank gives Cannara more financial flexibility. This could lead to increased operational growth and a larger market share.
Bear case
Despite the positive financing news, the stock's beta of 0.36 suggests lower volatility. This may limit short-term trading opportunities for investors looking for quick gains.
Price Action Overview
Advertisement
Cannara Biotech Inc. (LOVE.TO) closed at C$2.00, reflecting no change in price for the day. Over the past week, the stock has gained 1.53%, contributing to a year-to-date increase of 8.15%. The recent performance suggests stable interest from investors, particularly following the company’s latest financing announcement.
Company News Catalyst
On September 10, Cannara Biotech announced the expansion of its financing to an $80 million syndicated credit facility with BMO and TD Bank. This strategic move aims to strengthen Cannara’s financial foundation and support its continued growth in the competitive cannabis market. The financing is expected to provide the necessary capital for expansion and operational improvements.
Technical Picture
Cannara's stock is currently trading above its 50-day moving average of C$1.93, indicating a bullish sentiment in the short term. The 200-day moving average stands at C$1.81, also reflecting positive momentum with a 10.3% increase relative to the current price. The stock has shown a 52-week trading range of C$1.55 to C$2.07, with current trading at approximately 87% of this range. The volume for the latest trading session was 81,772 shares, significantly higher than the 20-day average volume of 35,225 shares, suggesting increased investor interest.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
